Galderma Group AG (VIE:GALD)

Austria flag Austria · Delayed Price · Currency is EUR
176.00
+1.00 (0.57%)
At close: Dec 5, 2025
Market Cap 41.26B
Revenue (ttm) 3.99B
Net Income (ttm) 321.87M
Shares Out n/a
EPS (ttm) 1.35
PE Ratio 128.18
Forward PE 48.38
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 176.00
Previous Close 175.00
Day's Range 176.00 - 176.00
52-Week Range 149.00 - 177.00
Beta n/a
RSI 71.45
Earnings Date Jul 23, 2026

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology. ... [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 6,545
Stock Exchange Vienna Stock Exchange
Ticker Symbol GALD
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.